These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1562905)

  • 1. A comparison of CT contrast enhancement and BUDR labeling indices in moderately and highly anaplastic astrocytomas of the cerebral hemispheres.
    McDermott MW; Krouwer HG; Asai A; Ito S; Hoshino T; Prados MD
    Can J Neurol Sci; 1992 Feb; 19(1):34-9. PubMed ID: 1562905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in the proliferative potential of human gliomas.
    Hoshino T; Nagashima T; Cho KG; Davis RL; Donegan J; Slusarz M; Wilson CB
    J Neurooncol; 1989 Jul; 7(2):137-43. PubMed ID: 2550593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas.
    Hoshino T; Prados M; Wilson CB; Cho KG; Lee KS; Davis RL
    J Neurosurg; 1989 Sep; 71(3):335-41. PubMed ID: 2549222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.
    Hoshino T; Ahn D; Prados MD; Lamborn K; Wilson CB
    Int J Cancer; 1993 Feb; 53(4):550-5. PubMed ID: 8382191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between bromodeoxyuridine-labeling indices and patient prognosis in cerebral astrocytic tumors of adults.
    Fujimaki T; Matsutani M; Nakamura O; Asai A; Funada N; Koike M; Segawa H; Aritake K; Fukushima T; Houjo S
    Cancer; 1991 Mar; 67(6):1629-34. PubMed ID: 2001552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
    Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
    J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
    Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
    Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases.
    Labrousse F; Daumas-Duport C; Batorski L; Hoshino T
    J Neurosurg; 1991 Aug; 75(2):202-5. PubMed ID: 1649271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling.
    Ito S; Hoshino T; Shibuya M; Prados MD; Edwards MS; Davis RL
    Neurosurgery; 1992 Sep; 31(3):413-8; discussion 419. PubMed ID: 1407423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative potential and prognostic evaluation of low-grade astrocytomas.
    Ito S; Chandler KL; Prados MD; Lamborn K; Wynne J; Malec MK; Wilson CB; Davis RL; Hoshino T
    J Neurooncol; 1994; 19(1):1-9. PubMed ID: 7815099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of histopathological features and proliferative potential of gliomas.
    Germano IM; Ito M; Cho KG; Hoshino T; Davis RL; Wilson CB
    J Neurosurg; 1989 May; 70(5):701-6. PubMed ID: 2709110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuploidy with survival or recurrence in brain-tumor patients.
    Nishizaki T; Orita T; Kajiwara K; Ikeda N; Ohshita N; Nakayama H; Furutani Y; Ikeyama Y; Akimura T; Kamiryo T
    J Neurosurg; 1990 Sep; 73(3):396-400. PubMed ID: 1696625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas.
    Chamberlain MC; Murovic JA; Levin VA
    Neurology; 1988 Sep; 38(9):1371-4. PubMed ID: 2842701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography in astrocytomas. A statistical analysis of the parameters of malignancy and the positive contrast-enhanced CT scan.
    Butler AR; Horii SC; Kricheff II; Shannon MB; Budzilovich GN
    Radiology; 1978 Nov; 129(2):433-9. PubMed ID: 212778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
    Maeda T; Hoshino T
    No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computerized tomography in the prognosis of malignant cerebral gliomas.
    Murovic J; Turowski K; Wilson CB; Hoshino T; Levin V
    J Neurosurg; 1986 Dec; 65(6):799-806. PubMed ID: 3021932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.
    Greenberg HS; Chandler WF; Diaz RF; Ensminger WD; Junck L; Page MA; Gebarski SS; McKeever P; Hood TW; Stetson PL
    J Neurosurg; 1988 Oct; 69(4):500-5. PubMed ID: 3047341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of the proliferative potential of low-grade astrocytomas.
    Hoshino T; Rodriguez LA; Cho KG; Lee KS; Wilson CB; Edwards MS; Levin VA; Davis RL
    J Neurosurg; 1988 Dec; 69(6):839-42. PubMed ID: 3193189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
    Nagashima T; Hoshino T
    No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index.
    Asai A; Hoshino T; Edwards MS; Davis RL
    Childs Nerv Syst; 1992 Aug; 8(5):273-8. PubMed ID: 1394266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.